Search for: "Price v. Maxwell "
Results 21 - 40
of 53
Sorted by Relevance
|
Sort by Date
23 Apr 2012, 1:08 pm
* "The price of silence and the myth of the Batt Cage", here. [read post]
26 Feb 2008, 9:41 am
State of Indiana (NFP) James Maxwell Cart v. [read post]
1 Nov 2006, 4:47 am
The IPKat thinks this is a jolly good publication and he'd like to be able to tell you the price, but there doesn't appear to be one. [read post]
10 Sep 2010, 5:51 am
On September 9, 2010, Chancellor Chandler issued his much-anticipated post-trial decision in eBay Domestic Holdings, Inc. v. [read post]
15 Jul 2009, 7:13 am
Sweet & Maxwell, ISBN 978-1-84703-787-9. [read post]
18 Dec 2009, 3:04 am
At US$225 it's fairly priced, given the relatively small and specialist market. [read post]
21 Oct 2021, 7:23 am
Price v. [read post]
21 Oct 2021, 7:23 am
Price v. [read post]
21 Oct 2021, 7:23 am
Price v. [read post]
30 Sep 2014, 1:48 pm
Fail to heed this warning and you will encounter some titles with a less rigorous legal content (e.g. here and here) ....Publisher: Sweet & Maxwell, ISBN: 9780414028685, Hardcover, 545 pages, Price: £175). [read post]
18 May 2023, 9:05 pm
Haushalter, D., Klasa, S., Maxwell, W.F., 2007. [read post]
23 Apr 2012, 7:02 am
Stung by a recent comment on this weblog about the lack of user-friendliness of publisher Sweet & Maxwell's website-- which was compared with that of Wolters Kluwer -- one of the IPKat's treasured contacts there has swiftly and positively sent him through some good news. [read post]
26 Feb 2010, 2:32 pm
Those cases are Black v. [read post]
6 Aug 2008, 5:33 pm
Price £225 (excluding delivery). [read post]
28 Oct 2022, 4:00 am
The price tag might not be great, given the state of the market, product overlap and consolidation, title renewal costs and the lack of viable competitive bidding, but the outcome, if it happened, could be impressive. [read post]
30 May 2016, 1:52 am
BaWan’s share prices soared after the win. [read post]
7 Feb 2020, 12:43 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]
20 Oct 2011, 6:18 pm
At any rate, Cotroneo involves the interrelation of Texas state law and the federal Price-Anderson Act, 42 U.S.C. [read post]
17 Aug 2017, 6:17 pm
Al Kassar, 660 F.3d 108, 118 (2d Cir. 2011). [4] United States v. [read post]
22 Feb 2011, 7:29 am
Price: $225. [read post]
